Beneficial Effects of Konjac-derived Glucosylceramide on Cognitive functio

Not Applicable

• Conditions: Healthy adult

• Registration Number: JPRN-UMIN000051463
• Lead Sponsor: Hokkaido Information University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-03
• Last Update Posted: 1 April 2024
• Study Completion: 2024-04-26

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects whose total MMSE score is <= 23 points. 2. Subjects who are under medication for dementia, Alzheimer's disease, psychiatric disorder and cerebrovascular disease. 3. Subjects with a history or suspected of psychiatric disorder and cerebrovascular disease. 4. Subjects with implantable electronic medical devices. 5. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal, respiratory diseases, and/or affected with infectious diseases requiring reports to the authorities. 6. Subjects with major surgical history relevant to the digestive system. 7. Subjects with unusually high and/or low blood pressure, abnormal physical data and/or abnormal hematological data. 8. Subjects with severe anemia. 9. Pre- or post-menopausal women complaining of obvious physical changes. 10. Subjects with dysphagia. 11. Subjects who may have allergic reactions to drugs, foods or plants (especially gelatin, mango, urushi, pistachio, cashew nut, latex rubber and birch). 12. Subjects who regularly take medicine, functional foods which would affect cognitive function. 13. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 14. Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks (men and women), or blood components within 2 weeks (men and women), prior to the current study. 15. Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 16. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified